سعر مينوفاكتور 75 وحدة دولية فيال 2022

Human menopausal gonadotrophin (hMG; FSH + LH) 75 IU for injection, 1 vial.

• Development of multiple follicles and pregnancy in ovulatory women as part of an assisted reproductive technology (ART) cycle (US indication).Population: Adult womenDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (>=2%) in ART: abdominal cramps, abdominal enlargement, abdominal pain, headache, injection-site pain, reaction and inflammation, and OHSS.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Prior hypersensitivity to menotropins or excipients; high FSH indicating primary ovarian failure; pregnancy; uncontrolled non-gonadal endocrinopathies (thyroid, adrenal, pituitary); sex-hormone-dependent tumours of the reproductive tract and accessory organs; tumours of the pituitary or hypothalamus; abnormal uterine bleeding of undetermined origin; ovarian cysts or enlargement not due to polycystic ovary syndrome.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Use only by physicians experienced in infertility treatment with appropriate monitoring; use the lowest effective dose. Risks include abnormal ovarian enlargement, ovarian hyperstimulation syndrome (OHSS) with possible pulmonary and vascular (thromboembolic) complications, ovarian torsion, multi-fetal gestation, congenital malformation, ectopic pregnancy, spontaneous abortion and ovarian neoplasms.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnancy (may cause fetal harm).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk; decide whether to discontinue nursing or the drug.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.